Jiangsu Delfu medical device Co.,Ltd

Jiangsu Delfu medical device Co.,Ltd Delfu Medical offers innovative diabetic and cardiac medical devices and OEM/ODM services for pharmaceutical, distributor and drug store world wide.

Manufacturer from China
Verified Supplier
11 Years
Home / Products / Continuous Glucose Monitor /

Fixed Dose Disposable Pen For Enoxaparin HGH Peptide

Contact Now
Jiangsu Delfu medical device Co.,Ltd
Visit Website
City:changzhou
Province/State:jiangsu
Contact Person:MrHyman Chow
Contact Now

Fixed Dose Disposable Pen For Enoxaparin HGH Peptide

Ask Latest Price
Video Channel
Brand Name :Delfu
Model Number :BZ-VI
Certification :ISO 13485,ISO 9001,ISO 14001
Place of Origin :China
MOQ :5000 Units
Price :USD 3-4
Payment Terms :T/T
Supply Ability :100,000 units per month
Delivery Time :7-14 Days
Contact Now

Add to Cart

Find Similar Videos
Electrical Driven Automatic Growth Hormone Injections Auto Insulin Pen For Child Diabetes 01:24
Electrical Driven Automatic Growth Hormone Injections Auto Insulin Pen For Child Diabetes
Electronic Insulin Pen Injector Needle Hidden Adjustable Multi Fixed Dose For Peptide 03:36
Electronic Insulin Pen Injector Needle Hidden Adjustable Multi Fixed Dose For Peptide
Disposable Insulin Injection Pen Safety Needles For 3ml Cartridge 00:08
Disposable Insulin Injection Pen Safety Needles For 3ml Cartridge
View Product Description

Product description

Fixed-dose disposable mechanical syringe, the syringe is original mechanical transmission, hand-press injection, the injection dose is fixed.

Product Features
①It is suitable for 3mL cartridge bottle conforming to ISO 11608-3 standard, and suitable for disposable injection pen needle conforming to ISO 11608-2 standard.
②The dose is fixed at 0.06mL, and the dose accuracy is in line with the international ISO 11608-1 standard.
③ Independent patented transmission technology, direct push medicine, safe and reliable.
④Super large dose display, with good readability, also suitable for patients with impaired vision.
⑤The dosage setting and correction operation is simple, and the patient's operability is good.

Test report number
QX2021B00308

Application

It is suitable for short-term and long-term injection treatment of fixed-dose biomedicine such as teriparatide and insulin.

Inquiry Cart 0
You May Like
DXCZ-001 Continuous Glucose Monitor Displays Glucose Levels and  Trends Every 5 minutes Up To 72 Hours
DXCZ-001 Continuous Glucose Monitor Displays Glucose Levels and Trends Every 5 minutes Up To 72 Hours
Send your message to this supplier
*From:
*To:

Jiangsu Delfu medical device Co.,Ltd

*Subject:
*Message:
Characters Remaining : (0/3000)
Contact Now